10-87863613-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The ENST00000692337.1(MLDHR):​c.55C>T​(p.Arg19*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000084 in 238,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. R19R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000084 ( 0 hom. )

Consequence

MLDHR
ENST00000692337.1 stop_gained

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0900

Publications

0 publications found
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
KLLN (HGNC:37212): (killin, p53 regulated DNA replication inhibitor) The protein encoded by this intronless gene is found in the nucleus, where it can inhibit DNA synthesis and promote S phase arrest coupled to apoptosis. The expression of this DNA binding protein is upregulated by transcription factor p53. [provided by RefSeq, Dec 2012]
KLLN Gene-Disease associations (from GenCC):
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 4
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTENNM_000314.8 linkc.-857C>T upstream_gene_variant ENST00000371953.8 NP_000305.3
KLLNNM_001126049.2 linkc.-1126G>A upstream_gene_variant ENST00000445946.5 NP_001119521.1 B2CW77

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLDHRENST00000692337.1 linkc.55C>T p.Arg19* stop_gained Exon 1 of 1 ENSP00000509326.1
PTENENST00000371953.8 linkc.-857C>T upstream_gene_variant 1 NM_000314.8 ENSP00000361021.3 P60484-1
KLLNENST00000445946.5 linkc.-1126G>A upstream_gene_variant 6 NM_001126049.2 ENSP00000392204.2 B2CW77

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000840
AC:
2
AN:
238080
Hom.:
0
Cov.:
0
AF XY:
0.0000165
AC XY:
2
AN XY:
120996
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
6742
American (AMR)
AF:
0.00
AC:
0
AN:
7130
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8786
East Asian (EAS)
AF:
0.00
AC:
0
AN:
22480
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2964
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
20668
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1250
European-Non Finnish (NFE)
AF:
0.0000131
AC:
2
AN:
152358
Other (OTH)
AF:
0.00
AC:
0
AN:
15702
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Aug 24, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Pathogenic
36
DANN
Benign
0.94
PhyloP100
0.090
PromoterAI
0.10
Neutral
Mutation Taster
=297/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587779996; hg19: chr10-89623370; API